Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.
Juanola A, Graupera I, Elia C, Piano S, Solé C, Carol M, Pérez-Guasch M, Bassegoda O, Escudé L, Rubio AB, Cervera M, Napoleone L, Avitabile E, Ma AT, Fabrellas N, Pose E, Morales-Ruiz M, Jiménez W, Torres F, Crespo G, Solà E, Ginès P.
Juanola A, et al. Among authors: graupera i.
J Hepatol. 2022 Jan;76(1):107-114. doi: 10.1016/j.jhep.2021.08.031. Epub 2021 Sep 13.
J Hepatol. 2022.
PMID: 34530063
Free article.